Clinical application of liquid biopsy to identify predictive and resistance biomarkers in stage IV breast cancer patients treated with CDK4/6 inhibitors
HR+/HER2- stage IV breast cancer patients are treated with a combination of CDK4/6 inhibitors plus endocrine therapy (ET). Nevertheless, all patients will develop intrinsic or acquired resistance, but there are not predictive biomarkers identified so far. Hence, in this thesis, it was proved that th...
Descripción completa
Detalles Bibliográficos
| Autor: |
González Conde, Miriam |
|---|
| Tipo de recurso: | tesis doctoral
|
|---|
| Fecha de publicación: | 2024 |
|---|
| País: | España |
|---|
| Institución: | Universidad de Santiago de Compostela (USC) |
|---|
| Repositorio: | Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela |
|---|
| Idioma: | inglés |
|---|
| OAI Identifier: | oai:minerva.usc.gal:10347/32922 |
|---|
| Acceso en línea: | http://hdl.handle.net/10347/32922
|
|---|
| Access Level: | acceso abierto |
|---|
| Palabra clave: | 320101 Oncología |
|---|
